4,177
Views
40
CrossRef citations to date
0
Altmetric
Research Paper

Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China

, ORCID Icon, , , , , , , , , ORCID Icon, , , , & show all
Pages 4873-4888 | Received 31 Jul 2021, Accepted 18 Nov 2021, Published online: 14 Dec 2021

Figures & data

Figure 1. Flowchart of the sampling process. In stage two, two cities in each province other than Hubei were selected: the capital city with a relatively higher socio-economic level and higher level of the pandemic, and a non-capital city with a relatively lower socio-economic level and lower level of the pandemic. Four cities in Hubei were selected, the capital city and three non-capital cities, based on the same stratification method of social-economic level and the pandemic scale, because the Hubei was the most severely impacted by the pandemic.

Figure 1. Flowchart of the sampling process. In stage two, two cities in each province other than Hubei were selected: the capital city with a relatively higher socio-economic level and higher level of the pandemic, and a non-capital city with a relatively lower socio-economic level and lower level of the pandemic. Four cities in Hubei were selected, the capital city and three non-capital cities, based on the same stratification method of social-economic level and the pandemic scale, because the Hubei was the most severely impacted by the pandemic.

Table 1. Participant characteristics

Table 2. Comparison of COVID-19 vaccination intention and perception among respondents with different age and NCD status, (%, 95% CI)

Figure 2. Reasons for COVID-19 vaccine hesitancy in adults aged 18–59 and the elderly. Chi-square tests were used to examine differences in the proportion of each reason between participant groups by ages and NCD status. Between the adults aged 18–59 and the elderly, the proportions of reasons that have significant differences are “concern about vaccine safety” and “vaccine supply may be inadequate” are (p < .05). Between the adults aged 18–59 with and without NCD, the proportions of reasons that have significant differences are “concern about vaccine price,” “vaccine supply may be inadequate” and “vaccination may take too much time” (p < .05). The p-value of the chi-square test in the proportion of “the vaccine may not be effective” is 0.052. Between the elderly with and without NCD, no significant differences are found among the reasons. The p-value of the chi-square test in the proportion of “wait and see others getting vaccinated” is 0.051.

Figure 2. Reasons for COVID-19 vaccine hesitancy in adults aged 18–59 and the elderly. Chi-square tests were used to examine differences in the proportion of each reason between participant groups by ages and NCD status. Between the adults aged 18–59 and the elderly, the proportions of reasons that have significant differences are “concern about vaccine safety” and “vaccine supply may be inadequate” are (p < .05). Between the adults aged 18–59 with and without NCD, the proportions of reasons that have significant differences are “concern about vaccine price,” “vaccine supply may be inadequate” and “vaccination may take too much time” (p < .05). The p-value of the chi-square test in the proportion of “the vaccine may not be effective” is 0.052. Between the elderly with and without NCD, no significant differences are found among the reasons. The p-value of the chi-square test in the proportion of “wait and see others getting vaccinated” is 0.051.

Table 3. Influence factors of willingness to accept COVID-19 vaccine by multiple logistic regressions

Table 4. Information sources for COVID-19 vaccines and vaccination among respondents with different age and NCD status, (%, 95% CI)

Table A1. Influence of demographic factors on COVID-19 vaccination intention among the total sample (n = 7259)

Table A2. Associations between COVID-19 vaccination intention and perception among respondents in groups of adult aged 18–59 and the elderly, (%, 95% CI)

Supplemental material

Supplemental Material

Download ()

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.